Ardelyx (ARDX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ARDX is expected to report earnings to fall 28.57% to -5 cents per share on November 07

Q3'24

Est.

$-0.05

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.03

Q4'23

Missed

by $0.03

Q3'23

Beat

by $0.14

The last earnings report on August 01 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 6.47M shares outstanding, the current market capitalization sits at 1.57B.

View a ticker or compare two or three

Compare

ARDX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ARDX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ARDX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

400 Fifth Avenue

Phone

+1 510 745-1700

Employees

267

Web

https://www.ardelyx.com